Predictions
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€105.80
08.03.23
08.03.23
€120.43
08.03.24
08.03.24
6.62%
09.03.24
09.03.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.80
07.03.23
07.03.23
€122.89
07.03.24
07.03.24
8.21%
08.03.24
08.03.24
Universal Health Services B
Start price
Target price
Perf. (%)
€117.92
06.03.23
06.03.23
€135.81
06.03.24
06.03.24
37.38%
07.03.24
07.03.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€449.75
04.03.23
04.03.23
-
04.03.24
04.03.24
-1.39%
05.03.24
05.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€299.80
03.03.23
03.03.23
€339.30
03.03.24
03.03.24
142.83%
04.03.24
04.03.24
Universal Health Services B
Start price
Target price
Perf. (%)
€120.22
03.03.23
03.03.23
€143.96
03.03.24
03.03.24
33.92%
04.03.24
04.03.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€450.10
28.02.23
28.02.23
€569.31
28.02.24
28.02.24
1.53%
29.02.24
29.02.24
Henry Schein Inc.
Start price
Target price
Perf. (%)
€74.17
28.02.23
28.02.23
€91.27
28.02.24
28.02.24
-4.57%
29.02.24
29.02.24
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€289.75
29.05.23
29.05.23
-
29.05.24
29.05.24
22.71%
15.02.24
15.02.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€37.76
02.02.24
02.02.24
-
-
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€153.36
24.01.23
24.01.23
€160.00
24.01.24
24.01.24
-4.60%
25.01.24
25.01.24
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.96
02.01.24
02.01.24
€80.00
02.02.24
02.02.24
-6.29%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€526.00
14.12.23
14.12.23
€558.00
14.12.24
14.12.24
0.57%
18.12.23
18.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€568.50
11.10.23
11.10.23
€558.00
11.10.24
11.10.24
-7.48%
14.12.23
14.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market